Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec 3;101 Suppl 2(Suppl 2):S102-9.
doi: 10.1038/sj.bjc.6605399.

Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results?

C S Thomson  1 , D Forman
Affiliations

Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results?

C S Thomson et al. Br J Cancer. .

Abstract

Background: This review of the EUROCARE-4 results attempts to separate out the early and late mortality effects contributing to the widely reported poorer 5-year survival rates for cancer patients in the United Kingdom compared with other European countries for 26 cancer sites.

Methods: Patients diagnosed with cancer in 1996-1999 in 23 European countries were included in the analyses. Comparison of 1-year, 5-year and 5|1-year (i.e. only including those patients who had survived to 1 year) survival estimates between data for England and the 'European average' was undertaken. This analysis was to highlight the relative contribution of early diagnosis, using 1-year survival as a proxy measure, on 5-year survival for the different sites of cancer. Three groups of cancer sites were identified according to whether the survival differences at 1, 5 and 5|1-years were statistically significant.

Results and conclusions: Breast cancer showed significantly poorer 1- and 5-year survival estimates in England, but the 5|1-year survival figure was not significantly different. Thus, successful initiatives around awareness and early detection could eradicate the survival gap. In contrast, the 5|1-year survival estimates remained significantly worse for lung, colorectal and prostate cancers, showing that although early detection could make some difference, late effects such as treatment and management of the patients were also influencing long-term outcome differences between England and Europe.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Five-year survival of patients diagnosed 1995–1999 from the EUROCARE-4 Study followed up to until the end of 2003, age-standardised % relative survival, ‘European average’ and England.
Figure 2
Figure 2
One-year survival of patients diagnosed 1995–1999 from the EUROCARE-4 Study followed up to until the end of 2003, age-standardised % relative survival, ‘European average’ and England.
Figure 3
Figure 3
5∣1-year survival of patients diagnosed 1995–1999 from the EUROCARE-4 Study followed up to until the end of 2003, age-standardised % relative survival, ‘European average’ and England.
See this image and copyright information in PMC

References

    1. Abdel-Rahman M, Stockton D, Rachet B, Hakulinen T, Coleman MP (2009) What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer 101(Suppl 2): S115–S124 - PMC - PubMed
    1. Berrino F, Capocaccia R, Coleman MP, Estève J, Gatta G, Hakulinen T, Micheli A, Sant M, Verdecchia A (eds). (2003) EUROCARE-3: the survival of cancer patients diagnosed in Europe during 1990–1994. Ann Oncol 14(Suppl 5): 1–155 - PubMed
    1. Berrino F, Capocaccia R, Estève J, Gatta G, Hakulinen T, Micheli M, Sant M, Verdecchia A (eds). (1999) Survival of Cancer Patients in Europe: the EUROCARE-2 Study (IARC Scientific Publications No. 151). International Agency for Research on Cancer: Lyon
    1. Berrino F, De Angelis R, Sant M, Rosso S, Lasota MB, Coebergh JWW, Santaquilani M, EUROCARE Working Group (2007) Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–1999: results of the EUROCARE-4 study. Lancet Oncol 8: 773–783 - PubMed
    1. Berrino F, Estève J, Coleman MP (1995a) Basic issues in the estimation and comparison of cancer patient survival. In Survival of Cancer Patients in Europe: the EUROCARE Study (IARC Scientific Publications No. 132), Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J (eds), pp 1–14. International Agency for Research on Cancer (WHO): Lyon